正大天晴药业集团研究院国际人才招聘

公司简介

正大天晴药业集团股份有限公司是中国集科研,生产和销售为一体的大型综合型医药企业,2017年营业额人民币167亿元,在2016年度“中国医药工业百强榜”上列第16位,在2017年“中国医药研发产品线最佳工业企业”排名第1位。

www.cttq.com

招聘职位

Director, Immunotherapy (Immuno-Oncology focus) (技术总监:免疫治疗)
Location Nanjing, China (中国南京)
Description The successful candidate will participate in the design and validation of the next generation of immunotherapeutics. He/she will provide strategic and technical leadership across immuno-oncology projects and initiatives. In addition to supporting the expansion of our antibody portfolio, the candidate will continue to explore and introduce new technological tools, methodologies and knowledge to further expand the group’s immune-related capabilities. He/she will be working at a cross-functional level with different therapeutic focus areas to identify the best potential indication(s) to support clinical development.

该候选人将领导对下一代肿瘤免疫治疗新技术、新方法的探索工作。要求候选人具有扎实的生物学和免疫学基础,对于肿瘤新生抗原Neo-antigen、 T细胞生物学、肿瘤疫苗等领域具有第一手实践经验。

Qualifications ØPh.D. or equivalent in Immunology or Biology-related field (with post-doctoral experience in Immunology preferred).

ØSkills: Demonstrate thorough knowledge of basic principles and concepts in Molecular biology and Immunology. Extensive hands-on expertise in T cell biology, immune cell manipulations and other immunological techniques. Strong knowledge of the immuno-Oncology field.

ØPreferred qualifications: Expertise in Neo-antigen based cancer vaccine, TCR biology and gene editing. Experience leading or being the biology functional lead on a project in a pharmaceutical or biotech Company.

Ø

Director, Viro-immunotherapy and Gene Therapy(技术总监:分子病毒学与基因治疗)
Location Nanjing, China (中国南京)
Description The successful candidate will participate in the design and validation of the next generation of gene and immuno-therapeutics. The candidate will lead the Oncolytic Viruses (OVs) programs, a new class of therapeutic agents in the arsenal of drugs against cancer.  He/she will lead design, generation, in vitro and in vivo testing and development of oncolytic vectors, utilize and further enhance existing proprietary technologies.

该候选人将领导对下一代免疫和基因治疗新技术、新方法的探索工作。要求候选人具有扎实的分子生物学、病毒学和免疫学基础,对于慢病毒、腺病毒及其他相关病毒载体学 Vectorology、溶瘤病毒等领域具有第一手的实践经验。熟悉病毒应用、设计、制备、质控等关键技术环节。

Qualifications ØPh.D. + A solid background in virology (including viral genome analysis and manipulation), cell biology, tumor biology/immunology with interest in oncolytic virus therapy.

ØSkills: Demonstrate thorough knowledge of basic principles and concepts in Molecular biology and Immunology. Previous experience in vectorology, immunotherapy or oncolytic virus-therapy, working with animal models of human cancers and immunological assays are highly desirable. Strong knowledge of the immune-Oncology field.

ØPreferred qualifications: Expertise in other novel therapies, e.g. protein degradation pathway based therapies, is a plus. Experience leading or being the biology functional lead on a project in a pharmaceutical or biotech Company.

Ø

中国咨询电话:+86 13675152276

美国咨询电话:858-774-0534

邮    箱:   zhaowei@cttq.com  zhaowei025@foxmail.com

 

中国:江苏省南京市玄武区玄武大道699-8区9号楼,                     邮政编码:210023

美国:PO Box 261022, San Diego, CA 92196

US_BD@cttq.com